Our Research

PI: Steven Malin, MPI: Michal Schnaider Beeri, MPI: Mary Sano, Co-I: Fred Kobylarz, Co-I:David Zald, Co-I: Liangyuan Hu, Lead site: Rutgers, The State University of New Jersey, Other sites:Rutgers Biomedical and Health Sciences, Icahn School of Medicine at Mount Sinai

The Miller Lab is recruiting adults 60 years of age and older for a research study on Early Biomarkers of Cognitive Decline.

You may be eligible for this study if:

1. You are 60 years of age or older
2. You are cognitively healthy or cognitively impaired (including Mild Cognitive Impairment and Dementia)
3. You speak English
4. You can travel to the Rutgers Campuses in New Brunswick and Piscataway.

If you are eligible and agree to participate, you will be asked to complete three in-person appointments, approximately one hour each:

1. Consent and a cognitive function assessment
2. Video recording of the blood vessels in the eye and a fasting blood draw
3. Magnetic Resonance Imaging (MRI) brain scan

Participants will receive a $50 gift card for completing the study.
Thank you for considering this research opportunity. If you have any questions, please contact us at miller.lab@sebs.rutgers.edu.

Offspring of individuals diagnosed with Alzheimer’s disease (AD) and related dementias face an elevated risk for the disease. This study seeks to recruit individuals with ethnic or racial backgrounds from the Middle Eastern/North African (MENA) or South Asian subcontinents, aged 45-70, who have one or more parents with AD. Study participants will complete a series of assessments for factors that have been linked to AD. These include study visits every two years, involving surveys, cognitive assessments, language assessments, motor function tasks, blood tests, physical and neurological exams, and brain imaging.

Study anticipated to begin in spring 2024